Although it has been shown that many STAT3 inhibitors have anti-tumor effects in vitro, screening out inhibitors with high efficiency, low toxicity and fewer side effects is rather challenging, and further animal experiments have studied less in relation to the pharmacology and toxicology of related inhibitors. Here, STAT3 is linked to neoplasm.